Comparison of the Therapeutic Outcomes Between Surgical Resection and Percutaneous Ablation for Small Hepatocellular Carcinoma

详细信息    查看全文

• 作者：Kiyoshi Hasegawa MD ; PhD (1)
  Taku Aoki MD ; PhD (1)
  Takeaki Ishizawa MD ; PhD (1)
  Junichi Kaneko MD ; PhD (1)
  Yoshihiro Sakamoto MD ; PhD (1)
  Yasuhiko Sugawara MD ; PhD (1)
  Norihiro Kokudo MD ; PhD (1)
  
  1. Hepato-Biliary-Pancreatic Surgery Division ; Department of Surgery ; Graduate School of Medicine ; University of Tokyo ; Tokyo ; Japan
  
• 刊名：Annals of Surgical Oncology
• 出版年：2014
• 出版时间：June 2014
• 年：2014
• 卷：21
• 期：3-supp
• 页码：348-355
• 全文大小：367 KB
• 参考文献：1. Ikai, I, Arii, S, Okazaki, M (2007) Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 37: pp. 676-691 4X.2007.00119.x" target="_blank" title="It opens in new window">CrossRef
  2. Forner, A, Llovet, JM, Bruix, J (2012) Hepatocellular carcinoma. Lancet. 379: pp. 1245-1255 40-6736(11)61347-0" target="_blank" title="It opens in new window">CrossRef
  3. Omata, M, Lesmana, LA, Tateishi, R (2010) Asian Pacific Association for the study of the liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 4: pp. 439-474 CrossRef
  4. Makuuchi, M, Kokudo, N (2006) Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol. 12: pp. 828-829
  5. Imamura, J, Tateishi, R, Shiina, S (2008) Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol. 103: pp. 3057-3062 41.2008.02153.x" target="_blank" title="It opens in new window">CrossRef
  6. Llovet, JM, Vilana, R, Bru, C (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 33: pp. 1124-1129 4233" target="_blank" title="It opens in new window">CrossRef
  7. Livraghi, T, Lazzaroni, S, Meloni, F (2005) Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 92: pp. 856-858 4986" target="_blank" title="It opens in new window">CrossRef
  8. Chopra, S, Dodd, GD, Chanin, MP (2003) Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. AJR Am J Roentgenol. 180: pp. 697-701 4/ajr.180.3.1800697" target="_blank" title="It opens in new window">CrossRef
  9. Moser, MA, Kneteman, NM, Minuk, GY (2000) Research toward safer resection of the cirrhotic liver. HPB Surg. 11: pp. 285-297 45" target="_blank" title="It opens in new window">CrossRef
  10. Imamura, H, Sano, K, Sugawara, Y (2005) Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 12: pp. 16-22 4-004-0965-9" target="_blank" title="It opens in new window">CrossRef
  11. Mise, Y, Hasegawa, K, Satou, S (2011) Venous reconstruction based on virtual liver resection to avoid congestion in the liver remnant. Br J Surg. 98: pp. 1742-1751 CrossRef
  12. Yasunaga, H, Horiguchi, H, Matsuda, S (2012) Relationship between hospital volume and operative mortality for liver resection: data from the Japanese Diagnosis Procedure Combination database. Hepatol Res. 42: pp. 1073-1080 4X.2012.01022.x" target="_blank" title="It opens in new window">CrossRef
  13. Belghiti, J, Hiramatsu, K, Benoist, S (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 191: pp. 38-46 CrossRef
  14. Poon, RT, Fan, ST, Lo, CM (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1,222 consecutive patients from a prospective database. Ann Surg. 240: pp. 698-708
  15. Kishi, Y, Abdalla, EK, Chun, YS (2009) Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 250: pp. 540-548
  16. Nguyen, KT, Marsh, JW, Tsung, A (2011) Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. Arch Surg. 146: pp. 348-356 48" target="_blank" title="It opens in new window">CrossRef
  17. Kasugai, H, Osaki, Y, Oka, H (2007) Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Oncology. 72: pp. 72-75 CrossRef
  18. Lang, BH, Poon, RT, Fan, ST (2003) Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg. 138: pp. 1207-1213 CrossRef
  19. Makuuchi, M, Hasegawa, H, Yamazaki, S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 161: pp. 346-350
  20. Hasegawa, K, Kokudo, N, Imamura, H (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 242: pp. 252-259 401.db" target="_blank" title="It opens in new window">CrossRef
  21. Eguchi, S, Kanematsu, T, Arii, S (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery. 143: pp. 469-475 CrossRef
  22. Bleicher, RJ, Allegra, DP, Nora, DT (2003) Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol. 10: pp. 52-58 45/ASO.2003.03.018" target="_blank" title="It opens in new window">CrossRef
  23. Lam, VW, Ng, KK, Chok, KS (2008) Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg. 207: pp. 20-29 CrossRef
  24. Komorizono, Y, Oketani, M, Sako, K (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 97: pp. 1253-1262 CrossRef
  25. Lu, DS, Raman, SS, Limanond, P (2003) Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol. 14: pp. 1267-1274 CrossRef
  26. Livraghi, T, Meloni, F, Stasi, M (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?. Hepatology. 47: pp. 82-89 CrossRef
  27. Shiina, S, Teratani, T, Obi, S (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 129: pp. 122-130 4.009" target="_blank" title="It opens in new window">CrossRef
  28. N鈥橩ontchou, G, Mahamoudi, A, Aout, M (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology. 50: pp. 1475-1483 CrossRef
  29. Obara, K, Matsumoto, N, Okamoto, M (2008) Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma. Hepatol Int. 2: pp. 116-123 40-3" target="_blank" title="It opens in new window">CrossRef
  30. Poon, RT, Ng, KK, Lam, CM (2004) Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol. 11: pp. 281-289 45/ASO.2004.08.018" target="_blank" title="It opens in new window">CrossRef
  31. Huang, GT, Lee, PH, Tsang, YM (2005) Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg. 242: pp. 36-42 CrossRef
  32. Chen, MS, Li, JQ, Zheng, Y (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 243: pp. 321-328 480.65519.b8" target="_blank" title="It opens in new window">CrossRef
  33. Hasegawa, K, Kokudo, N, Makuuchi, M (2008) Surgery or ablation for hepatocellular carcinoma?. Ann Surg. 247: pp. 557-558 CrossRef
  34. Huang, J, Yan, L, Cheng, Z (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 252: pp. 903-912 CrossRef
  35. Feng, K, Yan, J, Li, X (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 57: pp. 794-802 CrossRef
  36. Hasegawa, K, Kokudo, N, Shiina, S (2010) Surgery versus radiofrequency ablation for small hepatocellular carcinoma: start of a randomized controlled trial (SURF trial). Hepatol Res. 40: pp. 851-852 4X.2010.00696.x" target="_blank" title="It opens in new window">CrossRef
  37. Hasegawa, K, Kokudo, N, Makuuchi, M (2013) Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol. 458: pp. 714-719
  38. Ishizawa, T, Hasegawa, K, Aoki, T (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 134: pp. 1908-1916 CrossRef
  39. Torzilli, G, Donadon, M, Marconi, M (2008) Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Arch Surg. 143: pp. 1082-1190 43.11.1082" target="_blank" title="It opens in new window">CrossRef
  40. Arii, S, Yamaoka, Y, Futagawa, S (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 32: pp. 1224-1229 456" target="_blank" title="It opens in new window">CrossRef
  
• 刊物主题：Surgical Oncology; Oncology; Surgery;
• 出版者：Springer US
• ISSN：1534-4681

文摘

There seems to be a consensus in regard to the initial treatment of small hepatocellular carcinomas (HCCs): either percutaneous ablation or liver resection should be selected. Liver resection provides for excellent local control, which is one of the most important factors to be considered in the treatment of HCC. However, percutaneous ablation has the advantage of less invasiveness, which allows for repeated sessions of ablation. However, there has been a longstanding debate on which of the two therapeutic modalities might be superior in individual cases with various tumor-related and liver function factors. Although it is practically difficult to conduct randomized controlled trials (RCTs) to compare these two therapeutic modalities, there have been four RCTs published in English, which we focus on in this review article. We discuss the aforementioned unsolved problem according to the results of these RCTs, in addition to the results of a large-scale cohort study and the recommendations of clinical practice guidelines.